{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:08:50Z","timestamp":1792030130994,"version":"4.4.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minciencias","award":["651777757697"],"award-info":[{"award-number":["651777757697"]}]},{"name":"Minciencias convocatoria para el fortalecimiento de proyectos CTeI en ciencias m\u00e9dicas y de la salud con talento joven e impacto regional.","award":["850"],"award-info":[{"award-number":["850"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peripheral arterial disease is atherosclerotic occlusive disease of the lower extremity arteries and afflicts hundreds of millions of individuals worldwide. Its most severe manifestation is chronic limb-threatening ischemia (Petersen et al. (Science 300(5622):1140\u20132, 2003)), which is associated with severe pain at rest in the limbs, which progresses to necrosis, limb amputation, and\/or death of the patient. Consequently, the care of these patients is considered a financial burden for both patients and health systems. Multidisciplinary endeavors are required to address this refractory disease and to find definitive solutions that lead to improved living conditions. Revascularization is the cornerstone of therapy for preventing limb amputation, and both open vascular surgery and endovascular therapy play a key role in the treatment of patients with CLI. Around one-third of these patients are not candidates for conventional surgical treatment, however, leading to higher amputation rates (approaching 20\u201325% at one year) with high morbidity and lower quality of life. Advances in regenerative medicine have enabled the development of cell-based therapies that promote the formation of new blood vessels. Particularly, mesenchymal stem cells (MSCs) have emerged as an attractive therapeutic agent in various diseases, including CLI, due to their role in tissue regeneration and immunomodulation. This review discusses the characteristics of MSCs, as well as their regenerative properties and their action mechanisms on CLI.<\/jats:p>","DOI":"10.1186\/s13287-022-03043-3","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:18:59Z","timestamp":1658927939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential"],"prefix":"10.1186","volume":"13","author":[{"given":"Laura V.","family":"Lozano Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lady Tatiana","family":"Girat\u00e1 Viviescas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ardila-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Luna-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia L.","family":"Sossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-1512","authenticated-orcid":false,"given":"Martha L.","family":"Arango-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"issue":"5622","key":"3043_CR1","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.1082889","volume":"300","author":"KF Petersen","year":"2003","unstructured":"Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300(5622):1140\u20132.","journal-title":"Science"},{"issue":"2","key":"3043_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1358863X20987612","volume":"26","author":"S Giannopoulos","year":"2021","unstructured":"Giannopoulos S, Armstrong EJ. Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia. Vasc Med. 2021;26(2):210\u201324.","journal-title":"Vasc Med"},{"key":"3043_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13047-019-0351-0","volume":"12","author":"A Mizzi","year":"2019","unstructured":"Mizzi A, Cassar K, Bowen C, Formosa C. The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review. J Foot Ankle Res. 2019;12:40.","journal-title":"J Foot Ankle Res"},{"issue":"1","key":"3043_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1358863X19878271","volume":"25","author":"A Fereydooni","year":"2020","unstructured":"Fereydooni A, Gorecka J, Dardik A. Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapy. Vasc Med. 2020;25(1):78\u201387.","journal-title":"Vasc Med"},{"issue":"2","key":"3043_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jvs.2017.09.026","volume":"67","author":"JGJ Wijnand","year":"2018","unstructured":"Wijnand JGJ, Teraa M, Gremmels H, van Rhijn-Brouwer FCC, de Borst GJ, Verhaar MC, S.S. Group. Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia. J Vasc Surg. 2018;67(2):656\u201361.","journal-title":"J Vasc Surg"},{"key":"3043_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/VHRM.S209241","volume":"15","author":"S Duff","year":"2019","unstructured":"Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 2019;15:187\u2013208.","journal-title":"Vasc Health Risk Manag"},{"key":"3043_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.868370","volume":"9","author":"J Lin","year":"2022","unstructured":"Lin J, Chen Y, Jiang N, Li Z, Xu S. Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019. Front Cardiovasc Med. 2022;9: 868370.","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"3043_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009724","volume":"7","author":"JA Mustapha","year":"2018","unstructured":"Mustapha JA, Katzen BT, Neville RF, Lookstein RA, Zeller T, Miller LE, Jaff MR. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018;7(16): e009724.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3043_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ahj.2014.11.016","volume":"169","author":"MR Jaff","year":"2015","unstructured":"Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Am Heart J. 2015;169(4):479\u201385.","journal-title":"Am Heart J"},{"key":"3043_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051282","author":"F Simon","year":"2022","unstructured":"Simon F, Duran M, Garabet W, Schelzig H, Jacobs M, Gombert A. Gene therapy of chronic limb-threatening ischemia: vascular medical perspectives. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11051282.","journal-title":"J Clin Med"},{"key":"3043_CR11","doi-asserted-by":"publisher","first-page":"6795274","DOI":"10.1155\/2022\/6795274","volume":"2022","author":"FM Yusoff","year":"2022","unstructured":"Yusoff FM, Nakashima A, Kawano KI, Kajikawa M, Kishimoto S, Maruhashi T, Ishiuchi N, Abdul Wahid SFS, Higashi Y. Implantation of hypoxia-induced mesenchymal stem cell advances therapeutic angiogenesis. Stem Cells Int. 2022;2022:6795274.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3043_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jvs.2017.09.057","volume":"68","author":"SK Wang","year":"2018","unstructured":"Wang SK, Green LA, Drucker NA, Motaganahalli RL, Fajardo A, Murphy MP. Rationale and design of the clinical and histologic analysis of mesenchymal stromal cells in am putations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia. J Vasc Surg. 2018;68(1):176-181.e1.","journal-title":"J Vasc Surg"},{"issue":"1","key":"3043_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, Hua D, Shao C, Shi Y. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022;7(1):92.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"3043_CR14","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76(17):3323\u201348.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3043_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s13770-021-00334-3","volume":"18","author":"TT Van Nguyen","year":"2021","unstructured":"Van Nguyen TT, Vu NB, Van Pham P. Mesenchymal stem cell transplantation for ischemic diseases: mechanisms and challenges. Tissue Eng Regen Med. 2021;18(4):587\u2013611.","journal-title":"Tissue Eng Regen Med"},{"key":"3043_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12.","journal-title":"Cell Commun Signal"},{"key":"3043_CR17","unstructured":"Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A systemic review of the sources of adult mesenchymal stem cells and their suitability in musculoskeletal applications, Curr Stem Cell Res Ther; 2017."},{"key":"3043_CR18","doi-asserted-by":"crossref","unstructured":"Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine, Int J Mol Sci. 2017; 18(9).","DOI":"10.3390\/ijms18091852"},{"issue":"1","key":"3043_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40001-017-0258-9","volume":"22","author":"S Schneider","year":"2017","unstructured":"Schneider S, Unger M, van Griensven M, Balmayor ER. Adipose-derived mesenchymal stem cells from liposuction and resected fat are feasible sources for regenerative medicine. Eur J Med Res. 2017;22(1):17.","journal-title":"Eur J Med Res"},{"issue":"4","key":"3043_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000448180","volume":"43","author":"L Frese","year":"2016","unstructured":"Frese L, Dijkman PE, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43(4):268\u201374.","journal-title":"Transfus Med Hemother"},{"key":"3043_CR21","doi-asserted-by":"crossref","unstructured":"Mansilla E, Marin GH, Berges M, Scafatti S, Rivas J, Nunez A, Menvielle M, Lamonega R, Gardiner C, Drago H, Sturla F, Portas M, Bossi S, Castuma MV, Pena Luengas S, Roque G, Martire K, Tau JM, Orlandi G, Tarditti A. Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns, Burns Trauma 3. 2015; 17.","DOI":"10.1186\/s41038-015-0018-4"},{"issue":"1","key":"3043_CR22","first-page":"10","volume":"14","author":"C Galea","year":"2022","unstructured":"Galea C, Riva N, Calleja-Agius J. Non-gynaecological applications of menstrual-derived stem cells: a systematic review. Avicenna J Med Biotechnol. 2022;14(1):10\u201329.","journal-title":"Avicenna J Med Biotechnol"},{"issue":"5","key":"3043_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1634\/stemcells.22-5-823","volume":"22","author":"JR Smith","year":"2004","unstructured":"Smith JR, Pochampally R, Perry A, Hsu SC, Prockop DJ. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells. 2004;22(5):823\u201331.","journal-title":"Stem Cells"},{"issue":"11","key":"3043_CR24","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1002\/eji.201141542","volume":"41","author":"H Abdelrazik","year":"2011","unstructured":"Abdelrazik H, Spaggiari GM, Chiossone L, Moretta L. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol. 2011;41(11):3281\u201390.","journal-title":"Eur J Immunol"},{"issue":"3","key":"3043_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/ten.tec.2014.0206","volume":"21","author":"F Atashi","year":"2015","unstructured":"Atashi F, Jaconi ME, Pittet-Cuenod B, Modarressi A. Autologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion. Tissue Eng Part C Methods. 2015;21(3):253\u201362.","journal-title":"Tissue Eng Part C Methods"},{"issue":"9","key":"3043_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136621","volume":"10","author":"KA Russell","year":"2015","unstructured":"Russell KA, Gibson TW, Chong A, Co C, Koch TG. Canine platelet lysate is inferior to Fetal bovine serum for the isolation and propagation of canine adipose tissue- and bone marrow-derived mesenchymal stromal cells. PLoS ONE. 2015;10(9): e0136621.","journal-title":"PLoS ONE"},{"issue":"1","key":"3043_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13287-016-0352-x","volume":"7","author":"G Astori","year":"2016","unstructured":"Astori G, Amati E, Bambi F, Bernardi M, Chieregato K, Schafer R, Sella S, Rodeghiero F. Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem\/stromal cells: present and future. Stem Cell Res Ther. 2016;7(1):93.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3043_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000354061","volume":"40","author":"K Bieback","year":"2013","unstructured":"Bieback K. Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfus Med Hemother. 2013;40(5):326\u201335.","journal-title":"Transfus Med Hemother"},{"issue":"4","key":"3043_CR29","first-page":"315","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. Int Soc Cell Ther Position Statement Cytother. 2006;8(4):315\u20137.","journal-title":"Int Soc Cell Ther Position Statement Cytother"},{"issue":"10","key":"3043_CR30","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890\u20136.","journal-title":"Exp Hematol"},{"issue":"10","key":"3043_CR31","first-page":"1099","volume":"86","author":"K Mareschi","year":"2001","unstructured":"Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001;86(10):1099\u2013100.","journal-title":"Haematologica"},{"key":"3043_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcvm.2017.00032","volume":"4","author":"F Li","year":"2017","unstructured":"Li F, Guo X, Chen SY. Function and therapeutic potential of mesenchymal stem cells in atherosclerosis. Front Cardiovasc Med. 2017;4:32.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3043_CR33","first-page":"51","volume":"49","author":"RB Van Tongeren","year":"2008","unstructured":"Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, Van Bockel JH, Lindeman JH. Intramuscular or combined intramuscular\/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino). 2008;49(1):51\u20138.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"3043_CR34","volume":"2013","author":"TJ Kean","year":"2013","unstructured":"Kean TJ, Lin P, Caplan AI, Dennis JE. MSCs: Delivery Routes and Engraftment. Cell-Target Strateg Immune Modul Stem Cells Int. 2013;2013: 732742.","journal-title":"Cell-Target Strateg Immune Modul Stem Cells Int"},{"issue":"1","key":"3043_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","volume":"209","author":"GP Fadini","year":"2010","unstructured":"Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209(1):10\u20137.","journal-title":"Atherosclerosis"},{"issue":"9","key":"3043_CR36","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3727\/096368912X636948","volume":"21","author":"A Klepanec","year":"2012","unstructured":"Klepanec A, Mistrik M, Altaner C, Valachovicova M, Olejarova I, Slysko R, Balazs T, Urlandova T, Hladikova D, Liska B, Tomka J, Vulev I, Madaric J. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant. 2012;21(9):1909\u201318.","journal-title":"Cell Transplant"},{"issue":"2","key":"3043_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","volume":"58","author":"Z Dong","year":"2013","unstructured":"Dong Z, Chen B, Fu W, Wang Y, Guo D, Wei Z, Xu X, Mendelsohn FO. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia. J Vasc Surg. 2013;58(2):404-411e3.","journal-title":"J Vasc Surg"},{"issue":"6","key":"3043_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.yjmcc.2008.03.010","volume":"44","author":"C Steingen","year":"2008","unstructured":"Steingen C, Brenig F, Baumgartner L, Schmidt J, Schmidt A, Bloch W. Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J Mol Cell Cardiol. 2008;44(6):1072\u201384.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"3043_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5966\/sctm.2014-0203","volume":"4","author":"S Cosson","year":"2015","unstructured":"Cosson S, Otte EA, Hezaveh H, Cooper-White JJ. Concise review: tailoring bioengineered scaffolds for stem cell applications in tissue engineering and regenerative medicine. Stem Cells Transl Med. 2015;4(2):156\u201364.","journal-title":"Stem Cells Transl Med"},{"key":"3043_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13036-018-0133-4","volume":"12","author":"S Saberianpour","year":"2018","unstructured":"Saberianpour S, Heidarzadeh M, Geranmayeh MH, Hosseinkhani H, Rahbarghazi R, Nouri M. Tissue engineering strategies for the induction of angiogenesis using biomaterials. J Biol Eng. 2018;12:36.","journal-title":"J Biol Eng"},{"issue":"3","key":"3043_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15171\/jcvtr.2016.22","volume":"8","author":"M Hassanpour","year":"2016","unstructured":"Hassanpour M, Cheraghi O, Siavashi V, Rahbarghazi R, Nouri M. A reversal of age-dependent proliferative capacity of endothelial progenitor cells from different species origin in in vitro condition. J Cardiovasc Thorac Res. 2016;8(3):102\u20136.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"5985","key":"3043_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1187058","volume":"328","author":"SL Ameres","year":"2010","unstructured":"Ameres SL, Horwich MD, Hung JH, Xu J, Ghildiyal M, Weng Z, Zamore PD. Target RNA-directed trimming and tailing of small silencing RNAs. Science. 2010;328(5985):1534\u20139.","journal-title":"Science"},{"issue":"9","key":"3043_CR43","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1007\/s11095-010-0156-0","volume":"27","author":"KA Lennox","year":"2010","unstructured":"Lennox KA, Behlke MA. A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res. 2010;27(9):1788\u201399.","journal-title":"Pharm Res"},{"issue":"4","key":"3043_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.bbrc.2016.09.132","volume":"479","author":"SY Lee","year":"2016","unstructured":"Lee SY, Lee S, Lee J, Yhee JY, Yoon HI, Park SJ, Koo H, Moon SH, Lee H, Cho YW, Kang SW, Lee SY, Kim K. Non-invasive stem cell tracking in hindlimb ischemia animal model using bio-orthogonal copper-free click chemistry. Biochem Biophys Res Commun. 2016;479(4):779\u201386.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3043_CR45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cardiores.2005.02.006","volume":"66","author":"T Iwase","year":"2005","unstructured":"Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T, Kangawa K, Kitamura S. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res. 2005;66(3):543\u201351.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3043_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jcmm.12489","volume":"20","author":"N Xie","year":"2016","unstructured":"Xie N, Li Z, Adesanya TM, Guo W, Liu Y, Fu M, Kilic A, Tan T, Zhu H, Xie X. Transplantation of placenta-derived mesenchymal stem cells enhances angiogenesis after ischemic limb injury in mice. J Cell Mol Med. 2016;20(1):29\u201337.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"3043_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/cvr\/cvt250","volume":"101","author":"WH Huang","year":"2014","unstructured":"Huang WH, Chen HL, Huang PH, Yew TL, Lin MW, Lin SJ, Hung SC. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients. Cardiovasc Res. 2014;101(2):266\u201376.","journal-title":"Cardiovasc Res"},{"key":"3043_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2018.01.005","volume":"39","author":"NG Frangogiannis","year":"2018","unstructured":"Frangogiannis NG. Cell therapy for peripheral artery disease. Curr Opin Pharmacol. 2018;39:27\u201334.","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"3043_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jcyt.2016.12.003","volume":"19","author":"M Creane","year":"2017","unstructured":"Creane M, Howard L, O\u2019Brien T, Coleman CM. Biodistribution and retention of locally administered human mesenchymal stromal cells: Quantitative polymerase chain reaction-based detection of human DNA in murine organs. Cytotherapy. 2017;19(3):384\u201394.","journal-title":"Cytotherapy"},{"issue":"7","key":"3043_CR50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1517\/14712598.2011.574119","volume":"11","author":"J Wang","year":"2011","unstructured":"Wang J, Liao L, Tan J. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions. Expert Opin Biol Ther. 2011;11(7):893\u2013909.","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"3043_CR51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/0192623309338383","volume":"37","author":"Y Ramot","year":"2009","unstructured":"Ramot Y, Meiron M, Toren A, Steiner M, Nyska A. Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery. Toxicol Pathol. 2009;37(5):606\u201316.","journal-title":"Toxicol Pathol"},{"issue":"11","key":"3043_CR52","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/stem.217","volume":"27","author":"L Zangi","year":"2009","unstructured":"Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells. 2009;27(11):2865\u201374.","journal-title":"Stem Cells"},{"issue":"4","key":"3043_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/scrt119","volume":"3","author":"A Liew","year":"2012","unstructured":"Liew A, O\u2019Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther. 2012;3(4):28.","journal-title":"Stem Cell Res Ther"},{"key":"3043_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080784","author":"X Fu","year":"2019","unstructured":"Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8080784.","journal-title":"Cells"},{"key":"3043_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0076-6879(06)20016-8","volume":"420","author":"NW Marion","year":"2006","unstructured":"Marion NW, Mao JJ. Mesenchymal stem cells and tissue engineering. Methods Enzymol. 2006;420:339\u201361.","journal-title":"Methods Enzymol"},{"key":"3043_CR56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","volume":"15","author":"M Ullah","year":"2019","unstructured":"Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421\u201338.","journal-title":"iScience"},{"issue":"1","key":"3043_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3043_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCRESAHA.118.314290","volume":"125","author":"G Arderiu","year":"2019","unstructured":"Arderiu G, Pena E, Aledo R, Juan-Babot O, Crespo J, Vilahur G, Onate B, Moscatiello F, Badimon L. MicroRNA-145 regulates the differentiation of adipose stem cells toward microvascular endothelial cells and promotes angiogenesis. Circ Res. 2019;125(1):74\u201389.","journal-title":"Circ Res"},{"key":"3043_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2995","author":"AE Shafei","year":"2017","unstructured":"Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, Talaat KA, Ashaal AE, El-Shal AS. Mesenchymal stem cell therapy: a promising cell-based therapy for treatment of myocardial infarction. J Gene Med. 2017. https:\/\/doi.org\/10.1002\/jgm.2995.","journal-title":"J Gene Med"},{"issue":"11","key":"3043_CR60","first-page":"1209","volume":"21","author":"CP Chen","year":"2006","unstructured":"Chen CP, Lee YJ, Chiu ST, Shyu WC, Lee MY, Huang SP, Li H. The application of stem cells in the treatment of ischemic diseases. Histol Histopathol. 2006;21(11):1209\u201316.","journal-title":"Histol Histopathol"},{"issue":"4","key":"3043_CR61","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1253\/circj.CJ-15-1169","volume":"80","author":"LZ Guo","year":"2016","unstructured":"Guo LZ, Kim TH, Han S, Kim SW. Angio-vasculogenic properties of endothelial-induced mesenchymal stem cells derived from human adipose tissue. Circ J. 2016;80(4):998\u20131007.","journal-title":"Circ J"},{"key":"3043_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopha.2016.11.127","volume":"85","author":"M Ahmadi","year":"2017","unstructured":"Ahmadi M, Rahbarghazi R, Aslani MR, Shahbazfar AA, Kazemi M, Keyhanmanesh R. Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes. Biomed Pharmacother. 2017;85:28\u201340.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3043_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10456-010-9194-9","volume":"14","author":"S Kachgal","year":"2011","unstructured":"Kachgal S, Putnam AJ. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis. 2011;14(1):47\u201359.","journal-title":"Angiogenesis"},{"issue":"8","key":"3043_CR64","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3727\/096368908786576444","volume":"17","author":"M Leiker","year":"2008","unstructured":"Leiker M, Suzuki G, Iyer VS, Canty JM Jr, Lee T. Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells. Cell Transplant. 2008;17(8):911\u201322.","journal-title":"Cell Transplant"},{"key":"3043_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","volume":"1416","author":"M Gnecchi","year":"2016","unstructured":"Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016;1416:123\u201346.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3043_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11\u20135.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"3043_CR67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/atm.2017.03.50","volume":"5","author":"L Beer","year":"2017","unstructured":"Beer L, Mildner M, Ankersmit HJ. Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science. Ann Transl Med. 2017;5(7):170.","journal-title":"Ann Transl Med"},{"issue":"1","key":"3043_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15283\/ijsc.2009.2.1.59","volume":"2","author":"CW Park","year":"2009","unstructured":"Park CW, Kim KS, Bae S, Son HK, Myung PK, Hong HJ, Kim H. Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells. 2009;2(1):59\u201368.","journal-title":"Int J Stem Cells"},{"issue":"5","key":"3043_CR69","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5966\/sctm.2014-0267","volume":"4","author":"B Zhang","year":"2015","unstructured":"Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi H, Zhu Y, Wu L, Pan Z, Zhu W, Qian H, Xu W. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4\/beta-catenin pathway. Stem Cells Transl Med. 2015;4(5):513\u201322.","journal-title":"Stem Cells Transl Med"},{"key":"3043_CR70","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2014.00556","volume":"5","author":"R Blazquez","year":"2014","unstructured":"Blazquez R, Sanchez-Margallo FM, de la Rosa O, Dalemans W, Alvarez V, Tarazona R, Casado JG. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol. 2014;5:556.","journal-title":"Front Immunol"},{"issue":"5","key":"3043_CR71","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1021\/acs.molpharmaceut.0c00177","volume":"17","author":"Q Lv","year":"2020","unstructured":"Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020;17(5):1723\u201333.","journal-title":"Mol Pharm"},{"issue":"6","key":"3043_CR72","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/1574888X14666190228103230","volume":"14","author":"T Zhao","year":"2019","unstructured":"Zhao T, Sun F, Liu J, Ding T, She J, Mao F, Xu W, Qian H, Yan Y. Emerging role of mesenchymal stem cell-derived exosomes in regenerative medicine. Curr Stem Cell Res Ther. 2019;14(6):482\u201394.","journal-title":"Curr Stem Cell Res Ther"},{"key":"3043_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118002","volume":"256","author":"M Maqsood","year":"2020","unstructured":"Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L. Adult mesenchymal stem cells and their exosomes: sources, characteristics, and application in regenerative medicine. Life Sci. 2020;256: 118002.","journal-title":"Life Sci"},{"key":"3043_CR74","doi-asserted-by":"publisher","first-page":"4356359","DOI":"10.1155\/2020\/4356359","volume":"2020","author":"S Maacha","year":"2020","unstructured":"Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel JC, Cugno C. Paracrine mechanisms of mesenchymal stromal cells in angiogenesis. Stem Cells Int. 2020;2020:4356359.","journal-title":"Stem Cells Int"},{"issue":"4","key":"3043_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001886","volume":"3","author":"L Chen","year":"2008","unstructured":"Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE. 2008;3(4): e1886.","journal-title":"PLoS ONE"},{"key":"3043_CR76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.yjmcc.2014.04.012","volume":"72","author":"MC Chang","year":"2014","unstructured":"Chang MC, Tsao CH, Huang WH, Chih-Hsueh Chen P, Hung SC. Conditioned medium derived from mesenchymal stem cells overexpressing HPV16 E6E7 dramatically improves ischemic limb. J Mol Cell Cardiol. 2014;72:339\u201349.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"3043_CR77","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.bbadis.2013.08.002","volume":"1832","author":"YW Kwon","year":"2013","unstructured":"Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM, Lee MJ, Jang IH, Kwon SM, Lee JS, Kim JH. Tumor necrosis factor-alpha-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Biochim Biophys Acta. 2013;1832(12):2136\u201344.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3043_CR78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/scd.2013.0419","volume":"23","author":"SM Nassiri","year":"2014","unstructured":"Nassiri SM, Rahbarghazi R. Interactions of mesenchymal stem cells with endothelial cells. Stem Cells Dev. 2014;23(4):319\u201332.","journal-title":"Stem Cells Dev"},{"key":"3043_CR79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13287-015-0025-1","volume":"6","author":"QH Chen","year":"2015","unstructured":"Chen QH, Liu AR, Qiu HB, Yang Y. Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem Cell Res Ther. 2015;6:44.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3043_CR80","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4252\/wjsc.v7.i3.556","volume":"7","author":"MW Klinker","year":"2015","unstructured":"Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells. 2015;7(3):556\u201367.","journal-title":"World J Stem Cells"},{"issue":"5","key":"3043_CR81","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1634\/stemcells.2005-0271","volume":"24","author":"BR Son","year":"2006","unstructured":"Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006;24(5):1254\u201364.","journal-title":"Stem Cells"},{"issue":"1","key":"3043_CR82","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13287-018-1031-x","volume":"9","author":"SS Meng","year":"2018","unstructured":"Meng SS, Xu XP, Chang W, Lu ZH, Huang LL, Xu JY, Liu L, Qiu HB, Yang Y, Guo FM. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning. Stem Cell Res Ther. 2018;9(1):280.","journal-title":"Stem Cell Res Ther"},{"key":"3043_CR83","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (mscs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191.","journal-title":"Front Immunol"},{"key":"3043_CR84","doi-asserted-by":"publisher","first-page":"8179075","DOI":"10.1155\/2018\/8179075","volume":"2018","author":"KW Yong","year":"2018","unstructured":"Yong KW, Choi JR, Mohammadi M, Mitha AP, Sanati-Nezhad A, Sen A. Mesenchymal stem cell therapy for ischemic tissues. Stem Cells Int. 2018;2018:8179075.","journal-title":"Stem Cells Int"},{"issue":"9","key":"3043_CR85","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.medcli.2019.01.031","volume":"153","author":"WH Gao","year":"2019","unstructured":"Gao WH, Gao HY, Li YT, Huang PP. Effectiveness of umbilical cord mesenchymal stem cells in patients with critical limb ischemia. Med Clin (Barc). 2019;153(9):341\u20136.","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"3043_CR86","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/stem.3250","volume":"38","author":"J Liu","year":"2020","unstructured":"Liu J, Qiu P, Qin J, Wu X, Wang X, Yang X, Li B, Zhang W, Ye K, Peng Z, Lu X. Allogeneic adipose-derived stem cells promote ischemic muscle repair by inducing M2 macrophage polarization via the HIF-1alpha\/IL-10 pathway. Stem Cells. 2020;38(10):1307\u201320.","journal-title":"Stem Cells"},{"issue":"6","key":"3043_CR87","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1189\/jlb.0113043","volume":"94","author":"B Koscso","year":"2013","unstructured":"Koscso B, Csoka B, Kokai E, Nemeth ZH, Pacher P, Virag L, Leibovich SJ, Hasko G. Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages. J Leukoc Biol. 2013;94(6):1309\u201315.","journal-title":"J Leukoc Biol"},{"key":"3043_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7828","author":"A Galleu","year":"2017","unstructured":"Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS, von Bonin M, Barbieri L, Halai K, Ward S, Weng L, Chakraverty R, Lombardi G, Watt FM, Orchard K, Marks DI, Apperley J, Bornhauser M, Walczak H, Bennett C, Dazzi F. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aam7828.","journal-title":"Sci Transl Med"},{"key":"3043_CR89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mvr.2014.01.008","volume":"92","author":"K Liu","year":"2014","unstructured":"Liu K, Ji K, Guo L, Wu W, Lu H, Shan P, Yan C. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res. 2014;92:10\u20138.","journal-title":"Microvasc Res"},{"issue":"3","key":"3043_CR90","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1165\/rcmb.2013-0529OC","volume":"51","author":"X Li","year":"2014","unstructured":"Li X, Zhang Y, Yeung SC, Liang Y, Liang X, Ding Y, Ip MS, Tse HF, Mak JC, Lian Q. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol. 2014;51(3):455\u201365.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3043_CR91","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"11","author":"PK Gupta","year":"2013","unstructured":"Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, Krishnamurthy S, Anthony N, Pherwani A, Majumdar AS. A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013;11:143.","journal-title":"J Transl Med"},{"issue":"1","key":"3043_CR92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","volume":"92","author":"D Lu","year":"2011","unstructured":"Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, Xu J, Wu Q, Zhang Z, Xie B, Chen S. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92(1):26\u201336.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"3043_CR93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcyt.2013.11.011","volume":"16","author":"A Bura","year":"2014","unstructured":"Bura A, Planat-Benard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, Saint-Lebese B, Peyrafitte JA, Fleury S, Gadelorge M, Taurand M, Dupuis-Coronas S, Leobon B, Casteilla L. Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014;16(2):245\u201357.","journal-title":"Cytotherapy"},{"issue":"6","key":"3043_CR94","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0003319710364213","volume":"61","author":"GP Lasala","year":"2010","unstructured":"Lasala GP, Silva JA, Gardner PA, Minguell JJ. Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis. Angiology. 2010;61(6):551\u20136.","journal-title":"Angiology"},{"issue":"6","key":"3043_CR95","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/mt.2012.52","volume":"20","author":"RJ Powell","year":"2012","unstructured":"Powell RJ, Marston WA, Berceli SA, Guzman R, Henry TD, Longcore AT, Stern TP, Watling S, Bartel RL. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. Mol Ther. 2012;20(6):1280\u20136.","journal-title":"Mol Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03043-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T18:44:49Z","timestamp":1676227489000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03043-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03043-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"11 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable in this section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no conflict of interest could be perceived as prejudicing the impartiality of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}